Do Larger Health Insurance Subsidies Benefit Patients or Producers? Evidence from Medicare Advantage
NBER Working Paper No. 20470
Issued in September 2014, Revised in July 2017
NBER Program(s): AG HC HE IO PE
A central question in the debate over privatized Medicare is whether increased government payments to private Medicare Advantage (MA) plans generate lower premiums for consumers or higher profits for producers. Using difference-in-differences variation brought about by a sharp legislative change, we find that MA insurers pass through 45% of increased payments in lower premiums and an additional 9% in more generous benefits. We show that advantageous selection into MA cannot explain this incomplete pass-through. Instead, our evidence suggests that market power is important, with premium pass-through rates of 13% in the least competitive markets and 74% in the most competitive.
The NBER Bulletin on Aging and Health provides summaries of publications like this.
You can sign up to receive the NBER Bulletin on Aging and Health by email.
Machine-readable bibliographic record -
Document Object Identifier (DOI): 10.3386/w20470
Users who downloaded this paper also downloaded* these:
|Curto, Einav, Levin, and Bhattacharya
||w20818 Can Health Insurance Competition Work? Evidence from Medicare Advantage
|Duggan, Starc, and Vabson
||w19989 Who Benefits when the Government Pays More? Pass-Through in the Medicare Advantage Program
|Gruber and McKnight
||w20462 Controlling Health Care Costs Through Limited Network Insurance Plans: Evidence from Massachusetts State Employees
|Stockley, McGuire, Afendulis, and Chernew
||w20208 Premium Transparency in the Medicare Advantage Market: Implications for Premiums, Benefits, and Efficiency
|Duggan, Gruber, and Vabson
||w21650 The Efficiency Consequences of Health Care Privatization: Evidence from Medicare Advantage Exits